Researchers are investigating whether the drug could be used in mainstream medicine—with and without its hallucinatory ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

A rigorous new study finds that a single dose of LSD can ease a person's anxiety for months. NPR's Jon Hamilton reports that the study shows how research on psychedelics is entering the mainstream.

Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...